HarNeedi - Healthcare & Pharma Job Portal

Scientific intelligence, biopharma primary / secondary research, competitive intelligence and regulatory intelligence professionals will benefit from cognizance of key trends in the biopharma industry. For an instance: recent investigation of the Indian drug market has gathered substantial attention, as India seems poised to turn a major player in the pharmaceutical segment worldwide. This report provides some key trends and predictions. BY 2020: INDIAN PHARMACEUTICAL INDUSTRY TO REACH $55 BILLION According to India Ratings, a Fitch company, the Indian pharmaceutical industry is estimated to grow at 20 % compound annual growth rate (CAGR) over the next 5 years. The Indian pharma industry, which is expected to grow over 15 % per annum between 2015 and 2020, will outperform the global pharma industry, which is set to grow at an annual rate of 5 % between the same period. Presently the market size of the pharmaceutical industry in India stands at US$ 20 billion. This level of grow...

India is the largest supplier of medicine to US, and pharmaceutical exports from India raise from $3.44 bn in 2013 to $3.76 bn in 2014. ​Country’s pharma sector is likely to grow over three-fold to hit $55 billion in the next five years, even as the exports from the sector may slow down to grow at a CAGR of 7.98% owing to stricter regulations in markets such as the US, Russia and Africa, says a report. “Indian pharmaceutical industry is expected to touch $55 billion by 2020 as against the current size of $18 billion but the exports may slow down to grow at a CAGR of 7.98% in value terms due to tightening of regulatory mechanism in top exports markets of US, Russia and Africa,” a joint report by Assocham and TechSci Research reveals. With 70 percent of market share (in terms of revenues), generic drugs form the largest segment of  the Indian pharmaceutical sector , Consolidation of pharmacy players is leading to an increase in pricing pressures for generic companies existing in...